You are here

  • Home
  • Archive
  • Volume 32, Issue 5
  • Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial)

Article info

Article menu
Download PDFPDF
Clinical trial
Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial)

Authors

  1. Correspondence to Dr Glauco Baiocchi, Gynecologic Oncology, AC Camargo Cancer Center, São Paulo 01509-010, Brazil; glauco.baiocchi{at}accamargo.org.br
View Full Text

Citation

Baiocchi G, Andrade CEMC, Ribeiro R, et al
Sentinel lymph node mapping versus sentinel lymph node mapping with systematic lymphadenectomy in endometrial cancer: an open-label, non-inferiority, randomized trial (ALICE trial)
International Journal of Gynecologic Cancer 2022;32:676-679.

Publication history

  • Accepted February 14, 2022
  • First published March 2, 2022.
Online issue publication 
November 15, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.